Aequs Limited Grants 750,000 Employee Stock Options Under ESOP 2025
Aequs Limited's Nomination and Remuneration Committee approved the grant of 750,000 Employee Stock Options under ESOP 2025 on May 11, 2026, at an exercise price of INR 203.50 per option, covering equity shares of INR 10/- face value. The options carry a minimum vesting period of one year and must be exercised within three years of vesting, in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
*this image is generated using AI for illustrative purposes only.
The Nomination and Remuneration Committee ("NRC") of the Board of Directors of Aequs Limited has approved the grant of 750,000 Employee Stock Options ("Stock Options") under the Aequs Employee Stock Option Plan 2025 ("ESOP 2025") to eligible employees of the Company on May 11, 2026. The disclosure has been made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and is also in accordance with SEBI Circular No. HO/CFD/PoD2/I/3762/2026 dated January 30, 2026.
Key Details of the ESOP Grant
The grant covers 750,000 equity shares of face value INR 10/- each, with the exercise price set at INR 203.50 per Stock Option. This exercise price represents the last traded price of the equity shares of Aequs Limited on the National Stock Exchange of India Limited — the stock exchange with the highest trading volume — as on May 08, 2026, being the trading day immediately preceding the date of grant on May 11, 2026.
The following table summarises the key parameters of the ESOP 2025 grant:
| Parameter: | Details |
|---|---|
| Number of Stock Options Granted: | 750,000 |
| Scheme Name: | Aequs Employee Stock Option Plan 2025 (ESOP 2025) |
| Date of Grant: | May 11, 2026 |
| Exercise Price: | INR 203.50 per Stock Option |
| Face Value of Equity Shares: | INR 10/- each |
| Total Shares Covered: | 750,000 Equity Shares |
| Minimum Vesting Period: | 1 (One) Year from the date of Grant |
| Exercise Window: | Within 3 (Three) years from the date of respective vesting |
| Compliance: | SEBI (SBEB) Regulations, 2021 |
Vesting and Exercise Conditions
The Stock Options granted under ESOP 2025 are subject to a minimum vesting period of one year from the date of grant, with the full vesting schedule specified in the individual grant letters issued to eligible employees. Upon fulfilment of the applicable vesting conditions, vested options must be exercised within three years from the date of respective vesting. Once vested, each Stock Option entitles the holder to acquire one equity share of Aequs Limited upon payment of the exercise price and applicable taxes, in accordance with the terms and conditions of ESOP 2025.
Eligibility and Scheme Compliance
The grant of Stock Options is based upon the eligibility criteria as specified under ESOP 2025. The scheme is in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Assuming all granted options are vested and exercised, a total of 750,000 equity shares of face value INR 10/- each would arise as a result. Metrics such as options vested, options exercised, money realised by exercise, options lapsed, and diluted earnings per share are not applicable at this stage, as the current disclosure pertains solely to the grant of Stock Options under ESOP 2025.
Disclosure and Regulatory Compliance
The intimation has been filed under Regulation 30 of the SEBI Listing Regulations and is also in accordance with SEBI Circular No. HO/CFD/PoD2/I/3762/2026 dated January 30, 2026. The announcement is available on the Company's investor relations webpage. The disclosure was signed by Ravi Mallikarjun Hugar, Company Secretary and Compliance Officer (Membership Number: A20823), on May 11, 2026.
Historical Stock Returns for Aequs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +6.25% | -0.91% | +33.01% | +26.58% | +26.58% | +26.58% |
How might the dilution of 750,000 new equity shares impact Aequs Limited's earnings per share and existing shareholders' ownership percentage once options are fully vested and exercised?
What does the timing of the ESOP 2025 grant signal about Aequs Limited's talent retention strategy and competitive positioning within the aerospace and precision manufacturing sector?
If Aequs Limited's stock price significantly appreciates beyond the INR 203.50 exercise price over the vesting period, how could this affect employee motivation and the company's ability to attract top-tier talent in future hiring cycles?
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
